Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Ring Energy's 2026 annual stockholder meeting held on May 21, 2026. The filing presents voting outcomes for three proposals: election of seven directors (all duly elected), advisory approval of executive compensation, and ratification of Grant Thornton LLP as independent auditor. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Lazard held its Annual Meeting of Stockholders on May 21, 2026, with final voting results disclosed for five proposals: election of three directors (Orszag, Jarrard, Knobloch), a non-binding advisory vote on executive compensation, approval of a Certificate of Incorporation amendment to declassify the Board, approval of an amendment to the 2018 Incentive Compensation Plan, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Wingstop disclosed the complete results of its 2026 Annual Meeting of Stockholders held on May 21, 2026, including voting outcomes for director elections, auditor ratification, executive compensation advisory vote, and bylaw amendments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure presents the complete voting results from FB Financial Corporation's annual meeting of shareholders held on May 21, 2026, including election of 13 directors, approval of the 2026 Incentive Plan, approval of stock purchase plan amendments, advisory vote on named executive officer compensation, charter amendment proposal (which failed), and ratification of Crowe LLP as independent auditor. The detailed tabular voting results for each proposal are the hallmark of shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from Community Bancorp's Annual Meeting of Shareholders held on May 19, 2026. The filing reports voting outcomes for two proposals: election of two directors (Emma L. Marvin and Jacques R. Couture) and ratification of BDMP Assurance, LLP as external auditors. The detailed vote tallies and confirmation that both proposals passed are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 7.01
The CEO's remarks disclose material information about the company's liquidity strategy and portfolio performance, including a decline in net asset value from $0.27 to $0.29 per share driven by Denver multifamily market softness, and acknowledgment that "uncertainty around the terms, timing, and completion risk for one material transaction in our non-core portfolio delayed our ability to deliver a liquidity event." While the disclosure centers on forward-looking plans for a potential liquidity event rather than a completed transaction or specific executive action, the material transaction delays and NAV decline would affect a reasonable investor's assessment of the REIT's near-term prospects and shareholder value realization.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 5.03
iPower Inc. implemented a 1-for-8 reverse stock split of its common stock, approved by stockholders on December 21, 2025, and effective May 22, 2026. The reverse split affects share count, per-share metrics, and trading mechanics on Nasdaq, and was announced on May 19, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure reports the final voting results from Actuate Therapeutics' May 21, 2026 Annual Meeting of Stockholders, including the election of two Class II directors (Aaron G.L. Fletcher and Jason Keyes) and ratification of Crowe LLP as independent auditor. The tabulated vote counts for each proposal are the core content, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-05-22
Item 5.02
Michelle Burke resigned as Co-Chief Executive Officer and director of Z Squared Inc. effective May 22, 2026. While the filing also discloses that David Halabu continues as sole CEO, the principal disclosed action is Ms. Burke's departure from executive and board roles. The resignation is material as it represents a change in senior leadership at a company that recently completed a business combination (April 24, 2026).
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-22
Item 1.01
The filing discloses entry into a material definitive agreement—a $5.0 million revolving credit facility with nFusion Capital Finance, LLC. While this is a financing arrangement rather than a traditional M&A transaction, Item 1.01 is the appropriate disclosure vehicle for material definitive agreements. The secured credit facility with customary covenants, collateral requirements, and fees is material to the registrant's capital structure and liquidity position. However, the event is classified as ma_activity (the closest fit for material agreements affecting the registrant's financial position) rather than a more specific category, as the taxonomy lacks a dedicated financing event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's Annual Meeting of Shareholders held on May 22, 2026, covering three proposals: election of directors, advisory vote on named executive officer compensation, and ratification of the independent auditor. Item 5.07 explicitly requires disclosure of shareholder vote results, and the filing presents the voting tallies for each proposal with vote counts for, against, abstain, and broker non-votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Dianthus Therapeutics' Annual Meeting of Stockholders held on May 21, 2026. The filing presents final voting tallies for three proposals: election of Class II directors (Sujay Kango, Anne McGeorge, and Jonathan Violin, Ph.D.), advisory approval of executive compensation, and ratification of Deloitte & Touche, LLP as independent auditor. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and shareholder sentiment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-05-22
Item 8.01
The filing discloses a press release announcing net asset value (NAV) for the quarter ended March 31, 2026. For a closed-end investment company like Equus Total Return, Inc., quarterly NAV disclosure is a standard financial results announcement analogous to earnings releases for operating companies. This is material information that investors rely on to assess fund performance and value.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-22
Item 3.02
The filing discloses multiple unregistered equity issuances totaling approximately $3.8 million in Class E and Class I common shares issued on May 1 and May 20, 2026, pursuant to Section 4(a)(2) of the Securities Act. These include management fee payments to the Adviser (105,468 Class I shares), distribution reinvestment plan issuances to Brookfield affiliates (161,445 Class I shares and 91,337 Class E shares), and employee share sales (67,566 Class E shares). The cumulative dilutive effect and related-party nature of these transactions make this a material dilutive issuance event.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 7.01
The disclosure announces topline results from a Phase 2b clinical trial (LUMA study) for BIIB122 (DNL151), a Parkinson's disease candidate co-developed with Biogen. While clinical trial results are material to investors evaluating the company's pipeline and prospects, this does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, or other enumerated event types). The Regulation FD disclosure format and emphasis on trial outcomes support classification as a material event outside the specific categories.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 94%
filed 2026-05-22
Item 3.01
Anavex received a delinquency notification from Nasdaq on May 20, 2026, for failure to timely file its Form 10-Q, triggering non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until July 20, 2026, to submit a compliance plan and until November 16, 2026, to regain compliance, or face potential delisting proceedings.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-22
Item 5.03
Sadot Group Inc. approved and filed a 1-for-20 reverse stock split, effective May 27, 2026, explicitly intended to raise the per-share bid price above $1.00 to comply with Nasdaq Listing Rule 5550(a)(2) and address delisting risk. The amendment was disclosed via press release on May 22, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 discloses the results of Privia Health Group's 2026 Annual Meeting of Stockholders held on May 20, 2026, with detailed voting tallies for three proposals: election of three Class I directors (Nancy Cocozza, David King, and Francis Soistman), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals were approved by stockholders, making this a clear shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-05-22
Item 5.02
Jason Pello's departure as Chief Financial Officer effective April 3, 2026 is the principal disclosed action. While the filing also documents compensatory arrangements (consulting payments of $223,125 and continued vesting of RSUs), the core event is the CFO's separation from the Company. The departure of a named executive officer in a C-suite role is material to investors assessing management continuity and financial oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure reports the final results of Sotera Health's 2026 annual meeting of stockholders held on May 21, 2026, including voting outcomes on three matters: election of four Class III directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (For/Against/Withheld/Abstain/Broker Non-Votes) for each proposal are the core content, making this a textbook shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from Amalgamated Financial Corp.'s Annual Meeting of Stockholders held on May 20, 2026. The filing presents detailed vote tallies for three proposals: election of 13 directors, advisory approval of named executive officer compensation, and ratification of the independent auditor (Crowe LLP). This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-22
This 8-K discloses the completion of Berto Acquisition Corp. II's initial public offering (IPO) on May 18, 2026, raising $315.1 million in gross proceeds from the sale of 31.51 million units, plus a concurrent private placement of 3.5 million warrants for $3.5 million. While IPO completion is a material capital-raising event affecting the registrant's financial position and investor base, it does not fit neatly into the standard taxonomy categories (earnings_release, ma_activity, dilutive_issuance, etc.). The disclosure is material to investors as it establishes the company's public status and capital structure, but the event itself—an IPO completion—is best classified as other_material.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from Hayward Holdings' 2026 Annual Meeting of Stockholders held on May 21, 2026, covering three proposals: election of directors (Kevin D. Brown, Arthur L. Soucy, and Lori A. Walker), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors. The filing presents voting tallies (For/Against/Abstain/Broker Non-Votes) for each matter, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of GXO Logistics' 2026 annual meeting of stockholders held on May 20, 2026. The filing presents voting results for three matters: election of ten directors, ratification of KPMG LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the final voting results from A.K.A. Brands' annual meeting of stockholders held on May 20, 2026. The filing presents results for two matters: election of three directors (Wesley Bryett, Sourav Ghosh, and Kelly Thompson) and ratification of PricewaterhouseCoopers LLP as independent auditor. All three director nominees were elected with overwhelming support (98.8%+ votes for), and the auditor was ratified with 99.93% support. This is a material disclosure as it confirms the composition of the board and auditor for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from Angel Studios' May 21, 2026 annual meeting, reporting the election of five directors (Proposal 1) and ratification of Tanner LLP as independent auditor (Proposal 2), with detailed vote tallies for each nominee and proposal. This is the quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 45%
filed 2026-05-22
Item 1.01
Crescent Energy amended its credit facility, extending the maturity date to May 19, 2031, reducing the borrowing base from $3.9 billion to $3.5 billion, and providing favorable treatment for up to $600 million in new debt incurrences. This material amendment affects the company's liquidity, debt structure, and financial flexibility.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-22
Item 5.02
The filing discloses the appointment of Mr. Jeff Miller as a director of Noble Corporation plc, effective immediately on May 21, 2026, to fill a vacancy created by the Board's expansion to eight directors. While the section also mentions compensation arrangements, the principal disclosed action is the appointment of a new director to the Board, making this an exec_appointment event. Board composition changes are material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 99%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from UL Solutions' annual meeting held on May 20, 2026. The filing reports final vote tallies for three proposals: election of 12 directors (Proposal 1), ratification of PricewaterhouseCoopers LLP as independent auditor (Proposal 2), and advisory approval of named executive officer compensation (Proposal 3). All proposals passed with substantial majorities. This is a routine but material Item 5.07 disclosure required by SEC rules following shareholder meetings.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Stockholders voted at the Annual Meeting of Stockholders held on May 22, 2026, approving the election of three Class I directors (Thaddeus Darden, Michele J. Everard, Kirk Lazarine), ratification of Forvis Mazars LLP as independent auditor, advisory approval of named executive officer compensation, frequency of future compensation votes, and approval of amendments to the 2022 Omnibus Incentive Plan increasing available shares by 2,500,000 and extending the plan term to 2034.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-22
Item 8.01
Disclosure of fund portfolio composition, NAV per share ($4,618 million), portfolio fair value ($9,994 million), leverage ratios (1.21x debt-to-equity), and ongoing public offering activity ($3.9+ billion in Class I shares issued) as of April 30, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from the May 21, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: election of three Class III directors and ratification of Ernst & Young LLP as independent auditor, with specific vote tallies (For, Against/Withhold, Abstain, and Broker Non-Votes) for each proposal. Both proposals were approved. This directly matches Item 5.07 requirements and the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from Kenvue's 2026 Annual Meeting of Shareholders held on May 21, 2026. The filing presents final voting tallies for three proposals: election of 12 directors, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All proposals passed with substantial majorities. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure presenting the final voting results from Centuri Holdings' 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing reports results for four proposals: election of nine directors, advisory approval of executive compensation, approval of the ESPP, and ratification of PricewaterhouseCoopers LLP as independent auditor. All proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the final voting results from GE Vernova's annual meeting of stockholders held on May 20, 2026. The filing presents results for four matters: election of three Class II directors (Matthew Harris, Martina Hund-Mejean, Paula Rosput Reynolds), advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and a shareholder proposal on sustainability reporting (which failed). The disclosure is material as it documents the outcomes of governance votes that affect board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-22
This 8-K discloses routine monthly net asset value determinations, public offering price adjustments, and distribution declarations for CNL Strategic Capital, LLC—standard administrative disclosures for a closed-end fund. While the NAV, offering prices, and distributions are material to shareholders, they do not fit the specific event-type taxonomy (no earnings release, M&A, executive changes, impairments, covenant breaches, or other discrete triggering events). The filing is primarily informational rather than event-driven, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-22
Item 1.01
CNL Strategic Residential Credit entered into a First Amendment to its Loan and Security Agreement with Valley National Bank on May 22, 2026, expanding the existing $15 million revolving line of credit by an additional $5 million to support liquidity covenant compliance under existing repurchase agreement facilities. The amendment reflects the Company's need to enhance financial flexibility and maintain covenant compliance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the final voting results from Qnity's May 21, 2026 annual meeting of stockholders. The filing presents tabulated results for four matters: election of three Class I directors (Karin De Bondt, Byron Green, Jon Kemp), advisory approval of named executive officer compensation, frequency of future advisory compensation votes (approved as annual), and ratification of PricewaterhouseCoopers LLP as independent auditor. All votes passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-05-22
Item 1.01
Blue Owl Digital Infrastructure Trust entered into three separate Membership Interest Purchase Agreements to acquire 100% of membership interests in three data center entities for an aggregate purchase price of approximately $2.85 billion ($860.6M + $1.1B + $893.7M). This constitutes material acquisition activity under Item 1.01, involving substantial capital deployment and strategic expansion of the Trust's digital infrastructure portfolio. The transactions are significant in scale and directly material to investors assessing the registrant's growth strategy and financial position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Pinnacle Financial Partners' 2026 Annual Meeting held on May 21, 2026. The filing presents tabulated voting outcomes for five proposals: election of 15 directors, approval of the 2026 Omnibus Plan, advisory votes on executive compensation and frequency thereof, and ratification of KPMG LLP as independent auditor. All proposals passed with substantial majorities, making this a material governance event that investors rely upon to assess board composition and compensation oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
Alexander's Inc. held its 2026 Annual Meeting of Stockholders on May 21, 2026, with voting results on four proposals: election of three board nominees (DiBenedetto, Puri, Wight Jr.), approval of the 2026 Omnibus Stock Plan, a non-binding advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
Unum Group announced a Board-authorized increase in its quarterly dividend from an unstated prior rate to 50.5 cents per share ($2.02 annualized), effective Q3 2026. While dividend increases are material to shareholders and affect total shareholder return expectations, this disclosure does not fit neatly into the more specific event categories (it is not an earnings release, executive compensation arrangement, or shareholder vote result). The event is material to a reasonable investor but is best classified as other_material given the taxonomy's specificity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-21
Item 5.02
E. Morgan Flatley was elected to the Board of Directors of Constellation Brands, effective May 20, 2026, expanding the Board from 11 to 12 members. Ms. Flatley brings extensive executive experience from McDonald's and PepsiCo, and the Board determined her to be independent. Her compensation arrangements as a non-management director were also disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder voting results from JPMorgan Chase's Annual Meeting of Shareholders held May 19, 2026, covering seven proposals including director elections, executive compensation advisory vote, auditor ratification, and shareholder proposals. The filing presents detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures and material to investors assessing governance and shareholder sentiment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-21
Item 8.01
Ford completed a material restructuring of its EV battery joint venture on May 20, 2026, whereby it exited BOSK (redeeming its membership interest and terminating a $6.6 billion capital commitment), acquired two Kentucky battery plants through a subsidiary (FEB), and assumed a $3.8 billion DOE loan obligation. This constitutes a significant disposition and change in Ford's capital structure and strategic battery manufacturing footprint.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-21
Item 7.01
Graco Inc. announced it had signed a definitive agreement to acquire Valco Cincinnati, Inc. (doing business as Valco Melton), a global provider of adhesive application and quality assurance systems. The execution of a definitive acquisition agreement constitutes material M&A activity that would affect a reasonable investor's assessment of the company's strategic direction and financial position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-21
Item 5.02
Randy L. Hill was appointed to the board of directors to fill a vacancy created by W. Hayden McIlroy's death, and was also appointed to the audit committee.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-21
Item 5.07
Valhi Inc. held its 2026 annual meeting of stockholders on May 21, 2026, with shareholders approving the election of six directors (each receiving at least 93.6% approval) and an advisory say-on-pay vote on named executive officer compensation (93.9% approval).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a standard Item 5.07 disclosure of shareholder meeting voting results held on May 20, 2026. The filing presents detailed vote tallies for five proposals: director elections (all passed with strong majorities), advisory approval of executive compensation, ratification of Ernst & Young LLP as auditor, and two shareholder proposals (one on special meeting thresholds, one on charitable reporting). The disclosure is material as it documents shareholder approval of the board and auditor, which are fundamental governance matters affecting investor confidence.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from Trinity Industries' 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing reports voting outcomes on three proposals: election of eight directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. This is a quintessential Item 5.07 disclosure and is material to investors as it documents stockholder decisions on governance and executive compensation matters.
View raw filing on EDGAR →